Vecam 40/300
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vecam 40/300, covering 2010-01-27 to 2012-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms [Phase 2]